AC115619-22aa reduced overall m6A levels and inhibited tumor growth by binding to Wilms tumor 1-associated protein (WTAP) and hindering the assembly of the m6A methyltransferase complex [56] (Fig. 1). Here, WTAP is linked to neoplasm.